Skip to content

Azzly ® - Behavioral Health Practice Management Software

FacebookLinkedinX-twitterYoutubeSpotifyInstagram

Who We Serve
Features
Pricing Plans
Expert Services
- Software Implementation Plan
- Integrated Billing
Resources
(772) 567-0206

Who We Serve
Features
Pricing Plans
Expert Services
- Software Implementation Plan
- Integrated Billing
Resources
(772) 567-0206

Who We Serve
Features
Pricing Plans
Expert Services
- Software Implementation Plan
- Integrated Billing
Resources
(772) 567-0206

Who We Serve
Features
Pricing Plans
Expert Services
- Software Implementation Plan
- Integrated Billing
Resources
(772) 567-0206

Tag: Connecticut

Funding

$26 Billion Oxycontin Settlement Will Fund Drug Treatment Services in 14 States

14 states have agreed to a $26 billion settlement with

February 4, 2022 No Comments

AZZLY®: Behavioral Health EHR & EMR Software

Orlando, FL/Vero Beach, FL

1 (888) 400-3201

Useful Links

Programs We Serve
Software
Pricing Plan
Expert Services
Resources
The Team
Login
Contact

Who We Serve

Mental Health
Community-Based Outpatient
Inpatient Psychiatric Rehabilitation
Residential Treatment
Medication Management
Eating Disorder
Addiction Treatment
Medication Assisted Treatment
Abstinence-Based Treatment
Detox Inpatient-Outpatient
Office-Based Opioid Treatment (OBOT)
RCM Healthcare Services

Solutions

EMR/EHR
Outcome Measurement Tools
Billing/RCM
Analytics
Mobility
Learning Services
Patient Engagement
Consulting
Telehealth

LinkedinFacebookX-twitterInstagramYoutubeSpotify

American Owned & Operated. © Copyright 2025 AZZLY. All rights reserved | Powered by Visionation

| Home | Sitemap | Privacy Policy | Services Agreement | 1 (888) 400-3201 | Orlando, FL/Vero Beach, FL

Scroll to Top

Related Pages:

connecticut

Connecticut Drug Treatment Services Funded by $26 Billion Oxycontin Settlement

A recent $26 billion settlement involving the pharmaceutical company responsible for manufacturing Oxycontin will provide much-needed funding for drug treatment services in Connecticut and 13 other states. This landmark settlement aims to address the opioid epidemic that has ravaged communities across the country and support those struggling with addiction.

With this influx of funding, Connecticut will be able to expand access to addiction treatment programs, improve resources for prevention and education, and support recovery efforts for individuals and families affected by opioid addiction. This significant investment in drug treatment services is a crucial step towards combating the opioid crisis and providing support to those in need.

Related Pages:

connecticut

Connecticut Drug Treatment Services Funded by $26 Billion Oxycontin Settlement

A recent $26 billion settlement involving the pharmaceutical company responsible for manufacturing Oxycontin will provide much-needed funding for drug treatment services in Connecticut and 13 other states. This landmark settlement aims to address the opioid epidemic that has ravaged communities across the country and support those struggling with addiction.

With this influx of funding, Connecticut will be able to expand access to addiction treatment programs, improve resources for prevention and education, and support recovery efforts for individuals and families affected by opioid addiction. This significant investment in drug treatment services is a crucial step towards combating the opioid crisis and providing support to those in need.